Introduction
Jullien, Sinclair and Garner (2016) 1 (henceforth JSG) state that they seek to 'appraise the methods' of three recent papers that estimate long-run impacts of mass deworming on educational or economic outcomes. This commentary focuses on their discussion of Baird, Hicks, Kremer and Miguel (2016) 2 (henceforth Baird). We welcome scrutiny of our work, and appreciate the opportunity to discuss JSG. 1 Baird 2 finds evidence of gains in some educational and labour outcomes 10 years after a deworming programme in 75 Kenyan primary schools. Some gains are found in the full sample, and others among either males or females, in ways that are sensible given the context, e.g. there are gains in manufacturing employment among males but not females, fewer of whom work in this sector in Kenya. 2 ) Yet there are ample conceptual rationales for considering impacts for women and men separately. It is standard in economics to disaggregate labour market analysis by gender (Bertrand 2011 
Conclusion
The issue of selective reporting raised by JSG 1 is potentially important, but the evidence presented in JSG 1 does not change our interpretation of Baird 2 . It is JSG's right to interpret the evidence in their own way, of course, but we cannot help but feel that a more even-handed discussion would have been more productive for scientific progress. A more scientific assessment would discuss Baird's strengths as well as weaknesses, for example: the value of its long-term longitudinal data, which allow estimation of the benefit-cost ratio for mass deworming and suggest that long-run income gains might be 100 times the (small) initial cost. A more even-handed appraisal would not cherry-pick null results to highlight, present multiple testing adjustments in a tendentious fashion (in JSG 1 Table 6) or summarily dismiss analysis by gender in this context. The discussion could have mentioned a methodological strength of Baird, 2 namely, the fact that two orthogonal sources of variation-a cost-sharing experiment carried out in a random subset of schools (which lowered deworming drug take-up), and variation in exposure to crossschool treatment spillovers-both reinforce the main results.
It may be worth stepping back and thinking about the broader public policy debate regarding deworming. The decision to fund mass deworming should be based on comparing its expected costs and benefits, so even a small probability that the effects in Baird 2 are present would make the cost effectiveness analysis favourable. To be very concrete, was the Indian Government's recent decision to carry out mass school-based deworming-at pennies per dose (using safe and approved drugs) in areas with widespread infections-misguided and not 'informed by robust evidence', as JSG 1 suggest? It appears that even JSG 1 agree that deworming might be sensible and cost-effective in such a setting, when they write: 'If a community in a given setting has a high prevalence of untreated worm infections, then mass-deworming programmes may well be an effective way to reach and treat a large number of children'. 
